Literature DB >> 33797670

One-pot parallel synthesis of 1,3,5-trisubstituted 1,2,4-triazoles.

Dmytro S Radchenko1,2, Vasyl S Naumchyk1, Igor Dziuba3, Andrii A Kyrylchuk1,4, Kateryna E Gubina2, Yurii S Moroz2,3, Oleksandr O Grygorenko5,6.   

Abstract

An implementation of the three-component one-pot approach to unsymmetrical 1,3,5-trisubstituted-1,2,4-triazoles into combinatorial chemistry is described. The procedure is based on the coupling of amidines with carboxylic acids and subsequent cyclization with hydrazines. After the preliminary assessment of the reagent scope, the method had 81% success rate in parallel synthesis. It was shown that over a billion-sized chemical space of readily accessible ("REAL") compounds may be generated based on the proposed methodology. Analysis of physicochemical parameters shows that the library contains significant fractions of both drug-like and "beyond-rule-of-five" members. More than 10 million of accessible compounds meet the strictest lead-likeness criteria. Additionally, 195 Mln of sp3-enriched compounds can be produced. This makes the proposed approach a valuable tool in medicinal chemistry.
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Chemical space; Combinatorial chemistry; Heterocycles; Multicomponent reactions; Virtual libraries

Mesh:

Substances:

Year:  2021        PMID: 33797670      PMCID: PMC8486894          DOI: 10.1007/s11030-021-10218-2

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   3.364


  36 in total

1.  Is there a difference between leads and drugs? A historical perspective.

Authors:  T I Oprea; A M Davis; S J Teague; P D Leeson
Journal:  J Chem Inf Comput Sci       Date:  2001 Sep-Oct

Review 2.  Lead-oriented synthesis: a new opportunity for synthetic chemistry.

Authors:  Alan Nadin; Channa Hattotuwagama; Ian Churcher
Journal:  Angew Chem Int Ed Engl       Date:  2012-01-03       Impact factor: 15.336

Review 3.  The Symbiotic Relationship Between Drug Discovery and Organic Chemistry.

Authors:  Oleksandr O Grygorenko; Dmitriy M Volochnyuk; Sergey V Ryabukhin; Duncan B Judd
Journal:  Chemistry       Date:  2019-10-30       Impact factor: 5.236

4.  Facile One-Pot Parallel Synthesis of 3-Amino-1,2,4-triazoles.

Authors:  Andrey V Bogolyubsky; Olena Savych; Anton V Zhemera; Sergey E Pipko; Alexander V Grishchenko; Anzhelika I Konovets; Roman O Doroshchuk; Dmytro N Khomenko; Volodymyr S Brovarets; Yurii S Moroz; Mykhailo Vybornyi
Journal:  ACS Comb Sci       Date:  2018-06-18       Impact factor: 3.784

5.  Solid-phase synthesis of 5-amino-1-(substituted thiocarbamoyl)pyrazole and 1,2,4-triazole derivatives via dithiocarbazate linker.

Authors:  Jong Yeon Hwang; Hyung-Sub Choi; Duck-Hyung Lee; Sung-Eun Yoo; Young-Dae Gong
Journal:  J Comb Chem       Date:  2005 Jan-Feb

Review 6.  Deferasirox : a review of its use in the management of transfusional chronic iron overload.

Authors:  Lily P H Yang; Susan J Keam; Gillian M Keating
Journal:  Drugs       Date:  2007       Impact factor: 9.546

7.  Pharmacology of SC-52458, an orally active, nonpeptide angiotensin AT1 receptor antagonist.

Authors:  G M Olins; V M Corpus; S T Chen; E G McMahon; M A Palomo; D E McGraw; G J Smits; C L Null; M A Brown; S E Bittner
Journal:  J Cardiovasc Pharmacol       Date:  1993-10       Impact factor: 3.105

8.  ChEMBL: a large-scale bioactivity database for drug discovery.

Authors:  Anna Gaulton; Louisa J Bellis; A Patricia Bento; Jon Chambers; Mark Davies; Anne Hersey; Yvonne Light; Shaun McGlinchey; David Michalovich; Bissan Al-Lazikani; John P Overington
Journal:  Nucleic Acids Res       Date:  2011-09-23       Impact factor: 16.971

Review 9.  Giving AXL the axe: targeting AXL in human malignancy.

Authors:  Carl M Gay; Kavitha Balaji; Lauren Averett Byers
Journal:  Br J Cancer       Date:  2017-01-10       Impact factor: 7.640

10.  An open-source drug discovery platform enables ultra-large virtual screens.

Authors:  Andras Boeszoermenyi; Zi-Fu Wang; Christoph Gorgulla; Patrick D Fischer; Paul W Coote; Krishna M Padmanabha Das; Yehor S Malets; Dmytro S Radchenko; Yurii S Moroz; David A Scott; Konstantin Fackeldey; Moritz Hoffmann; Iryna Iavniuk; Gerhard Wagner; Haribabu Arthanari
Journal:  Nature       Date:  2020-03-09       Impact factor: 49.962

View more
  2 in total

1.  Creation of targeted compound libraries based on 3D shape recognition.

Authors:  Andrii Kyrylchuk; Iryna Kravets; Anton Cherednichenko; Valentyna Tararina; Anna Kapeliukha; Dmytro Dudenko; Mykola Protopopov
Journal:  Mol Divers       Date:  2022-05-24       Impact factor: 2.943

2.  The Ukrainian Factor in Early-Stage Drug Discovery in the Context of Russian Invasion: The Case of Enamine Ltd.

Authors:  Ivan S Kondratov; Yurii S Moroz; Oleksandr O Grygorenko; Andrey A Tolmachev
Journal:  ACS Med Chem Lett       Date:  2022-06-10       Impact factor: 4.632

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.